Hematology/Oncology News

In this video, Elizabeth Lee, MD, of the Dana-Farber Cancer Institute, highlighted promising endometrial cancer presentations from ESMO Congress.

Data from a phase 3 trial designed to compare pralsetinib with standard therapy for certain patients with advanced lung cancer revealed a risk for severe — and potentially fatal — infections with the drug, according to its manufacturer.

ORLANDO — Among patients with skin of color, women were more likely to be diagnosed with melanoma compared with men, according to a presentation at the American Society for Dermatologic Surgery Annual Meeting.

People with head and neck cancer experience depression twice as often as those with other types of cancer, according to results of a retrospective study.

Clinical and genetic risk factors can help identify individuals at risk for immune checkpoint inhibitor-induced diabetes, according to results of a cohort study.

A transperineal approach to prostate cancer biopsies without the need for preventive antibiotics could eliminate risk for infection, according to results of a randomized trial.

International medical graduates — physicians who complete medical school or equivalent outside of the U.S. or Canada — comprise almost one-third of all practicing U.S. oncologists.

The addition of daratumumab to maintenance lenalidomide extended PFS for patients who underwent stem cell transplant for newly diagnosed multiple myeloma, according to study results.

Individuals with no detectable hemoglobin in previously negative fecal immunochemical tests had a “significantly higher” harm-to-benefit ratio for screening, with researchers suggesting less intensive screening for this population.

Survival for people with hepatocellular carcinoma has improved over the last decade, according to study results.